Following the manufacture of sufficient supplies of the drug compound by ANP?s technology partner, Isis Pharmaceuticals Inc., ANP has now commenced formulation of this raw material into injectible product to be used in the clinical trial. This drug product formulation work should be completed in April 2011.
- Forums
- ASX - By Stock
- PER
- plenty of news coming soon
plenty of news coming soon
-
- There are more pages in this discussion • 27 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PER (ASX) to my watchlist
(20min delay)
|
|||||
Last
8.2¢ |
Change
0.001(1.23%) |
Mkt cap ! $76.63M |
Open | High | Low | Value | Volume |
8.1¢ | 8.5¢ | 8.1¢ | $45.71K | 553.6K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 33 | 8.2¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
8.4¢ | 51941 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 33 | 0.082 |
2 | 164616 | 0.081 |
5 | 215500 | 0.080 |
1 | 250000 | 0.079 |
2 | 41500 | 0.078 |
Price($) | Vol. | No. |
---|---|---|
0.084 | 51941 | 1 |
0.085 | 104271 | 2 |
0.087 | 125000 | 1 |
0.089 | 102263 | 2 |
0.090 | 146175 | 1 |
Last trade - 15.35pm 28/06/2024 (20 minute delay) ? |
Featured News
PER (ASX) Chart |
The Watchlist
LU7
LITHIUM UNIVERSE LIMITED
Alex Hanly, CEO
Alex Hanly
CEO
SPONSORED BY The Market Online